China Bank's RMB clearing volume in Australia exceeded 100 trillion yuan. According to Bank of China, recently, Bank of China Sydney Branch and Bank of China Hong Kong jointly held a RMB forum in Sydney to celebrate the 10th anniversary of being an Australian RMB clearing bank. As the only RMB clearing bank in the South Pacific at present, in the past ten years, China Bank has taken root in Australia and South Pacific, continuously expanded its clearing network, cooperated with four local banks and other financial institutions in Australia, and became the main channel for RMB clearing of local important banks, providing RMB clearing volume of more than 100 trillion yuan.Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.Poland signed an MQ-9B Sky Guardian UAV purchase contract with the United States. On December 12th, local time, Poland signed an MQ-9B Sky Guardian UAV purchase contract with the United States. Caussignac cames, Deputy Prime Minister and Minister of National Defense of Poland, stressed that the establishment of unmanned aerial vehicles (UAVs) is an "absolute priority" for Poland's security investment, and from January 1, 2025, UAVs will formally become a part of the Polish army. MQ-9B "Sky Guard" is mainly used for reconnaissance, monitoring and attack on ground and water targets, with a maximum takeoff weight of 5.67 tons and a maximum external store weight of 2.1 tons. (CCTV News)
Yiwangyichuang: Shareholder Zhang Fan plans to reduce his shareholding by no more than 1%. Yiwangyichuang announced that shareholder Zhang Fan, who holds more than 5% of the company's shares, plans to reduce his shareholding by centralized bidding and/or block trading, and the number of shares to be reduced is no more than 2,369,400, accounting for 1.00% of the company's total share capital. The reduction period is from January 6, 2025 to April 4, 2025. The price range of reduction will be determined according to the market price and trading method at the time of reduction. The reason for Zhang Fan's reduction is based on his own capital demand, and the shares come from the shares issued before the initial public offering, the shares transferred due to equity distribution and the shares transferred by agreement.Market News: A fire broke out at Kaliningrad Shipyard in Russia.HKEx: It is estimated that the T+1 settlement system will be ready by the end of 2025.
Yibin Paper: Terminate the issue of A shares to specific targets in 2022 and withdraw the application documents. Yibin Paper announced that the company held the 31st meeting of the 11th Board of Directors and the 22nd meeting of the 11th Board of Supervisors on December 12, 2024, and deliberated and passed the Proposal on Terminating the Issue of A shares to specific targets in 2022 and withdrawing the application documents. Considering the changes in market environment and policies, and considering the actual situation, the company decided to terminate the issuance of A shares to specific targets.Add 121.3 billion cubic meters! The proven reserves of Fuling shale gas field have exceeded one trillion cubic meters. The reporter learned from China Petrochemical today (12th) that China has made great progress in shale gas exploration. The proven reserves in Nanchuan block of Fuling shale gas field have increased by 121.356 billion cubic meters, and the accumulated proven reserves have reached one trillion cubic meters, which has added protection to national energy security. (CCTV News)Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.